Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Detection of EBV-encoded Small RNA from Diffuse Large B-cell Lymphoma Patients by RT-PCR Method

  • Yoo, Tae Hyun (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Lee, Min Ho (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Park, Min (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Lee, Jaewang (Department of Hospital Pathology, St. Vincent's Hospital, The Catholic University of Korea) ;
  • Woo, Hyun Jun (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Kim, Hyun Woo (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Yang, Ji Yeong (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Kwon, Hye Jin (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Yeon, Min Ji (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Kim, Jong-Bae (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
  • Received : 2015.09.17
  • Accepted : 2015.10.06
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Epstein-Barr virus (EBV) has a pathogenic role in several lymphomas including diffuse large B-cell lymphoma (DLBCL). In this study, we detected EBV from formalin-fixed paraffin embedded (FFPE) tissues of DLBCL patients by RT-PCR and compared the sensitivity of the RT-PCR method to in situ hybridization (ISH) method. The RNA was extracted from 91 FFPE samples with DLBCL and amplified with primers targeting EBV-encoded small RNA (EBER) by RT-PCR. When using the RT-PCR method, 13 of 91 patients (14.3%) were positive and among these 13 cases, 7 cases (7.7%) were from > 50-year-old patients that is classified as EBV positive DLBCL of the elderly. In previous results using ISH method, 3 of 91 patients (3.3%) were positive and 2 case (2.4%) were older than 50-year-old. These results indicate that RT-PCR method used in this study shows a higher sensitivity than ISH method. The ratio of male versus female among the EBV positive samples was 1.2:1 with the ratio of male higher. If RT-PCR method having high sensitivity is used simultaneously as well as the ISH method providing the information of the EBV positive cellular location, it is expected that EBV will be more accurately detected.

Keywords

References

  1. Anagnostopoulos I, Hummel M. Epstein-Barr virus in tumours. Histopathology. 1996. 29: 297-315. https://doi.org/10.1111/j.1365-2559.1996.tb01414.x
  2. Beltran BE, Castillo JJ, Morales D, de Mendoza FH, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Am J Hematol. 2011. 86: 663-667. https://doi.org/10.1002/ajh.22078
  3. Bonin S, Petrera F, Niccolini B, Stanta G. PCR analysis in archival postmortem tissues. Mol Pathol. 2003. 56: 184-186. https://doi.org/10.1136/mp.56.3.184
  4. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992. 1: 246-255. https://doi.org/10.1097/00019606-199203000-00037
  5. Epstein A. Thirty years of Epstein-Barr virus. Epstein-Barr virus Report. 1994. 1: 3-4.
  6. Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol. 2009. 40: 653-661. https://doi.org/10.1016/j.humpath.2008.10.007
  7. Gratama JW, Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res. 1995. 67: 197-255. https://doi.org/10.1016/S0065-230X(08)60714-9
  8. Hoeller S, Tzankov A, Pileri SA, Went P, Dirnhofer S. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol. 2010. 41: 352-357. https://doi.org/10.1016/j.humpath.2009.07.024
  9. Hofscheier A, Ponciano A, Bonzheim I, Adam P, Lome-Maldonado C, Vela T, Cortes E, Ortiz-Hidalgo C, Fend F, Quintanilla-Martinez L. Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol. 2011. 24: 1046-1054. https://doi.org/10.1038/modpathol.2011.62
  10. Iwakiri D, Eizuru Y, Tokunaga M, Takada K. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 2003. 63: 7062-7067.
  11. Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K. Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene. 2005. 24: 1767-1773. https://doi.org/10.1038/sj.onc.1208357
  12. Kashofer K, Viertler C, Pichler M, Zatloukal K. Quality control of RNA preservation and extraction from paraffin-embedded tissue: implications for RT-PCR and microarray analysis. PLoS One. 2013. 8: e70714. https://doi.org/10.1371/journal.pone.0070714
  13. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, Takada K. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J. 2000. 19: 6742-6750. https://doi.org/10.1093/emboj/19.24.6742
  14. Knipe DM, Howley PM. Fields Virology. 1996. 1: 2343-2396. Lippincott Williams & Wilkins. Philadelphia.
  15. Kuze T, Nakamura N, Hashimoto Y, Sasaki Y, Abe M. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population. Jpn J Cancer Res. 2000. 91: 1233-1240. https://doi.org/10.1111/j.1349-7006.2000.tb00909.x
  16. Lee J, Park M, Lee MH, Woo HJ, Kim HW, Yang JY, Eom YB, Kim SH, Yoon C, Kim JB. Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly. Int J Clin Exp Pathol. 2015. 8: 7859-7868.
  17. Montes-Moreno S, Odqvist L, Diaz-Perez JA, Lopez AB, de Villambrosia SG, Mazorra F, Castillo ME, Lopez M, Pajares R, Garcia JF, Mollejo M, Camacho FI, Ruiz-Marcellan C, Adrados M, Ortiz N, Franco R, Ortiz-Hidalgo C, Suarez-Gauthier A, Young KH, Piris MA. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-${\kappa}B$ activation. Mod Pathol. 2012. 25: 968-982. https://doi.org/10.1038/modpathol.2012.52
  18. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J. 2002. 21: 954-965. https://doi.org/10.1093/emboj/21.5.954
  19. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumours. Lancet. 1994. 343: 333-335. https://doi.org/10.1016/S0140-6736(94)91167-3
  20. Ok CY, Papathomas TG, Medeiros LJ, Young KH. EBV-positive diffuse large B-cell lymphoma of the elderly. Blood. 2013. 122: 328-340. https://doi.org/10.1182/blood-2013-03-489708
  21. Oyama T, Yamamoto K, Asano N, Oshiro A, Suzuki R, Kagami Y, Morishima Y, Takeuchi K, Izumo T, Mori S, Ohshima K, Suzumiya J, Nakamura N, Abe M, Ichimura K, Sato Y, Yoshino T, Naoe T, Shimoyama Y, Kamiya Y, Kinoshita T, Nakamura S. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007. 13: 5124-5132. https://doi.org/10.1158/1078-0432.CCR-06-2823
  22. Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 2007. 110: 972-978. https://doi.org/10.1182/blood-2007-01-067769
  23. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal. 2006. 8: 1473-1484. https://doi.org/10.1089/ars.2006.8.1473
  24. Qi ZL, Han XQ, Hu J, Wang GH, Gao JW, Wang X, Liang DY. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues. Mol Med Rep. 2013. 7: 89-92. https://doi.org/10.3892/mmr.2012.1163
  25. Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol. 1992. 3: 297-307.
  26. Rosa MD, Gottlieb E, Lerner MR, Steitz JA. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol. 1981. 1: 785-796. https://doi.org/10.1128/MCB.1.9.785
  27. Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011. 105: 1684-1692. https://doi.org/10.1038/bjc.2011.450
  28. Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol. 2010. 148: 739-753. https://doi.org/10.1111/j.1365-2141.2009.08010.x
  29. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997. 89: 3909-3918.
  30. Vinay K, Abul KA, Nelson F, Jon CA. Robbins & Cotran Pathologic Basis of Disease. 2010. 607. Saunders. Philadelphia.
  31. Yang L, Aozasa K, Oshimi K, Takada K. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res. 2004. 64: 5332-5337. https://doi.org/10.1158/0008-5472.CAN-04-0733